Courtney Roundy

Co-Founder & Chief Executive Officer, Tecton Ketones

Courtney Roundy is the Co-Founder and CEO of Tecton Ketones, a performance-driven metabolic health company advancing the clinical application of R-3 Hydroxybutyrate Glycerides (R3HBG), a patented, bioidentical ketone molecule with the potential to reshape energy regulation, cognitive function, and metabolic resilience. After a successful retirement from the consumer goods sector, Courtney re-entered the industry in 2024 to lead the commercialization of this breakthrough compound.

With more than three decades of executive leadership in consumer-packaged goods, Courtney has built and sold multiple high-growth companies, generating over $750 million in cumulative revenue.

Courtney’s career spans the full lifecycle of brand building from formulation, sourcing, and regulatory navigation to national retail distribution and exit that meet both consumer demand and acquisition criteria.

At Tecton Ketones, Courtney drives strategic partnerships, operational scalability, and go-to-market execution for a suite of products focused on cognition, GLP-1 support, metabolic restoration, and elite performance.

Meet Other Team Members

A Portion of All Proceeds Go To Support Veterans Facing Housing Insecurity